Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-III Rectal Cancer

Clinical trial NCT07394192 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07394192
Sponsor: Peking University Cancer Hospital & Institute
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rectal Cancer Radiotherapy PD-1 Inhibitor

Start date: 2026-02-01
Primary completion: 2028-12-31
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.